Topical calcipotriol combined with phototherapy for psoriasis - The results of two randomized trials and a review of the literature

被引:36
作者
Molin, L [1 ]
机构
[1] Orebro Med Ctr Hosp, Dept Dermatol, S-70185 Orebro, Sweden
关键词
psoriasis; calcipotriol; phototherapy; adverse events;
D O I
10.1159/000018151
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Calcipotrial has a well-documented effect in the treatment of psoriasis, Objective: To confirm the beneficial effect of the combination of calcipotriol and UVB and to demonstrate that the combination is safe and well tolerated, Methods: Data from two randomized right/left studies were analysed. Patients included in the studies had chronic stable plaque-type psoriasis with symmetrical lesions on the arms, the legs and/or the trunk. In one study, 101 patients were treated with calcipotriol on one side and calcipotriol + UVB on the other side of the body (open study). In the other study, 77 patients were treated with calcipotriol + UVB on one side and vehicle + UVB on the other side of the body (double-blind study). Calcipotriol ointment, 50 mu g/g, was applied twice daily and UVB 3 times weekly for 8 weeks. UVB was increased from 0.7 MED before treatment in rapid steps up to the erythema threshold. Result: In both treatment series the therapeutic effect of the combination of calcipotriol and UVB was enhanced as compared to calcipotriol alone and UVB alone. In the first series there was a significant reduction of the psoriasis area and severity index (PASI) with the combination after 2 weeks as compared to calcipotriol alone. At the end of treatment significantly more sides were cleared after calcipotriol + UVB than after calcipotriol alone. In the other series there was a significantly faster onset of improvement on the sides treated with calcipotriol + UVB than on those treated with vehicle + UVB, After 2 weeks there was a significant difference in PASI in favour of calcipotriol + UVB. At the end of treatment, however, there was no difference between the treatments. There was a similar adverse event profile with either treatment. The addition of UVB to calcipotriol did not alter the tolerability or safety of topically applied calcipotriol. Conclusions: The result indicates a beneficial effect of combining calcipotriol and phototherapy. The findings are compared to other published studies.
引用
收藏
页码:375 / 381
页数:7
相关论文
共 31 条
[1]   EFFECTS OF A NOVEL VITAMIN-D ANALOG MC-903 ON CELL-PROLIFERATION AND DIFFERENTIATION INVITRO AND ON CALCIUM-METABOLISM INVIVO [J].
BINDERUP, L ;
BRAMM, E .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (05) :889-895
[2]   SYNTHESIS OF MC-903, A BIOLOGICALLY-ACTIVE VITAMIN-D METABOLITE ANALOG [J].
CALVERLEY, MJ .
TETRAHEDRON, 1987, 43 (20) :4609-4619
[3]   COMPARATIVE-STUDY OF CALCIPOTRIOL (MC-903) OINTMENT AND BETAMETHASONE 17-VALERATE OINTMENT IN PATIENTS WITH PSORIASIS-VULGARIS [J].
CUNLIFFE, WJ ;
BERTHJONES, J ;
CLAUDY, A ;
FAIRISS, G ;
GOLDIN, D ;
GRATTON, D ;
HENDERSON, CA ;
HOLDEN, CA ;
MADDIN, WS ;
ORTONNE, JP ;
YOUNG, M ;
ADAM, JE ;
DODD, WA ;
RAMSAY, CA ;
AMBLARD, P ;
BONNETBLANC, JM ;
BOZZETTO, G ;
DENOEUX, JP ;
GUIDONI, JF ;
GUILHOU, JJ ;
LAROCHE, L ;
LAURET, P ;
LEPEYTRE, P ;
MOULIN, G ;
NOBLE, JP ;
PASQUIOU, C ;
SCHUBERT, B ;
VERRET, JL ;
POWELL, F ;
OLOUGHLIN, S ;
LYONS, F ;
CHALMERS, RJG ;
CHU, AC ;
ROWELL, NR ;
ELLIS, JP ;
FOULDS, I ;
GRIFFITHS, WAD ;
HARRINGTON, CI ;
HARRISON, PV ;
HUTCHINSON, PE ;
KLABER, MR ;
LOVELL, CR ;
MCGIBBON, DH ;
MILLER, JA ;
MISCH, KJ ;
PRICE, M ;
SAIHAN, EM ;
SHAMY, HK ;
VOLLUM, DI ;
WONG, E .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1992, 26 (05) :736-743
[4]  
DERIE MA, 1998, JOINT M 5 EUR C PSOR, P125
[5]   COMPARISON OF SUBERYTHEMOGENIC AND MAXIMALLY AGGRESSIVE ULTRAVIOLET-B THERAPY FOR PSORIASIS [J].
EELLS, LD ;
WOLFF, JM ;
GARLOFF, J ;
EAGLSTEIN, WH .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1984, 11 (01) :105-110
[6]  
Frappaz A, 1993, EUR J DERMATOL, V3, P351
[7]   SEVERE PSORIASIS - ORAL THERAPY WITH A NEW RETINOID [J].
FREDRIKSSON, T ;
PETTERSSON, U .
DERMATOLOGICA, 1978, 157 (04) :238-244
[8]   Topical calcipotriene in combination with UVB phototherapy for psoriasis [J].
Hecker, D ;
Lebwohl, M .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1997, 36 (04) :302-303
[9]  
Hecker D., 1995, Journal of Investigative Dermatology, V104, P659
[10]  
KERSCHER M, 1993, AKTUEL DERMATOL, V19, P151